Topiramate Capsule, Extended Release
Product Images NDC 67877-796

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 67877-796). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Topi-stru (Topi Stru)

Chemical structure diagram of topiramate, showing its molecular arrangement including rings, oxygen atoms, and sulfonamide group as depicted in the image.*

FDA Label Image

Topi-fig-1 (Topi Fig 1)

A Kaplan-Meier plot showing cumulative rates for time to first seizure over approximately 500 days. It compares two groups of Topiramate oral extended-release capsule users at dosages of 50 mg/day (solid line, N=234) and 400 mg/day (dotted line, N=235). The graph includes a p-value of 0.0002 indicating statistical comparison of the two dosage groups.*

FDA Label Image

Topi-fig-2 (Topi Fig 2)

Bar chart displaying the change from baseline to double-blind phase in average monthly migraine period rate (± SE) for placebo and topiramate at 50 mg/day, 100 mg/day, and 200 mg/day doses across two studies. The chart compares results between Study 1 and Study 2 groups, indicating statistical significance at p<0.010 and p<0.001 levels.*

FDA Label Image

Topiramate-caps-25mg-30s (Topi 25 30s F1)

Label for Topiramate Extended-Release Capsules, USP 25 mg by Ascend Laboratories, LLC. It includes usage instructions to swallow the capsule whole once daily and cautions against opening or crushing the capsule contents. The package contains 30 capsules. Manufacturer is Alkem Laboratories Ltd., India, and distribution is by Ascend Laboratories, LLC, NJ. Storage instructions and pharmacist dispensing advice are also present.*

FDA Label Image

Topiramate-caps-25mg-100s (Topi 25 100s F2)

Topiramate Extended-Release Capsules USP 25 mg label showing an oral extended-release capsule product. The label displays instructions to swallow the capsule whole and avoid crushing or chewing. It indicates a 100 count bottle, manufactured by Alkem Laboratories Ltd. in Mumbai, India, and distributed by Ascend Laboratories, LLC in Bedminster, NJ. The capsule is described as having a light green opaque body and yellow opaque cap.*

FDA Label Image

Topiramate-caps-25mg-500s (Topi 25 500s F3)

Label for Topiramate Extended-Release Capsules USP, 25 mg strength. Features dosage instructions to swallow whole once daily and pharmacist dispensing guidance, with a quantity of 500 capsules. Manufactured by Alkem Laboratories Ltd., India, and distributed by Ascend Laboratories, LLC, Bedminster, NJ. Includes barcode and storage instructions with capsule description as light green body and yellow cap.*

FDA Label Image

Topiramate-caps-25mg-10s (Topi 25 10s F4)

Label for Topiramate Extended-Release Capsules, USP 25 mg by Ascend Laboratories, LLC. The label indicates 10 capsules in a 1 x 10 unit-dose package. Capsules have a light green opaque body and yellow opaque cap. The label includes storage instructions, pharmacist directions, and manufacturing details by Alkem Laboratories Ltd., India.*

FDA Label Image

Topiramate-caps-50mg-30s (Topi 50 30s F5)

Label for Topiramate Extended-Release Capsules, USP 50 mg, oral extended-release capsules. The label includes dosing instructions, pharmacist dispensing guidance, and storage conditions. It also shows the NDC 67877-794-30, a 30-capsule count, and the labeler Ascend Laboratories, LLC, with manufacturing by Alkem Laboratories Ltd., Mumbai, India.*

FDA Label Image

Topiramate-caps-50mg-100s (Topi 50 100s F6)

Topiramate Extended-Release Capsules, USP 50 mg oral capsule label with light green opaque body and orange opaque cap. The label indicates 100 capsules per container, manufactured by Alkem Laboratories Ltd. in India, and distributed by Ascend Laboratories, LLC, Bedminster, NJ. Includes storage instructions and a barcode.*

FDA Label Image

Topiramate-caps-50mg-500s (Topi 50 500s F7)

Topiramate Extended-Release Capsules USP 50 mg capsule label showing a light green opaque body and orange opaque cap. Manufactured by Alkem Laboratories Ltd., Mumbai, India and distributed by Ascend Laboratories, LLC. The label includes storage instructions, dosing advisory, and a barcode. Package contains 500 capsules.*

FDA Label Image

Topiramate-caps-50mg-10s (Topi 50 10s F8)

Topiramate Extended-Release Capsules USP 50 mg packaging label displays the product name and strength prominently. The label indicates the capsules are extended-release, available in a 10-count unit-dose package. The dosage form is capsules with a light green body and orange cap. The labeler is Ascend Laboratories, LLC, with manufacturing by Alkem Laboratories Ltd., India. Storage and safety warnings are included.*

FDA Label Image

Topiramate-caps-100mg-30s (Topi 100 30s F9)

Label for Topiramate Extended-Release Capsules, USP 100 mg by Ascend Laboratories, LLC. The label includes dosage instructions to swallow whole once daily, packaging details for 30 capsules, and storage directions. Manufacturer is Alkem Laboratories Ltd., India, and distributor is Ascend Laboratories, Bedminster, NJ. A barcode is visible on the right side.*

FDA Label Image

Topiramate-caps-100mg-100s (Topi 100 100s F10)

Label for Topiramate Extended-Release Capsules USP, 100 mg strength, featuring a green opaque body and blue opaque cap capsule. The label includes dosing instructions to swallow the capsule whole, and cautions against opening or crushing the capsule. It shows the labeler as Ascend Laboratories, LLC, and manufacturer Alkem Laboratories Ltd., India. The package contains 100 capsules and includes a UPC barcode.*

FDA Label Image

Topiramate-caps-100mg-500s (Topi 100 500s F11)

Topiramate Extended-Release Capsules USP, 100 mg strength, oral extended-release capsules with a green opaque body and blue opaque cap. The label indicates a 500-capsule count and includes handling instructions. Manufactured by Alkem Laboratories Ltd., India, and distributed by Ascend Laboratories, LLC, Bedminster, NJ. The label also displays the NDC 67877-795-05 and Ascend Laboratories logo.*

FDA Label Image

Topiramate-caps-100mg-10s (Topi 100 10s F12)

Topiramate Extended-Release Capsules USP 100 mg carton label showing unit-dose packaging of 10 capsules. The label includes dosage instructions to swallow whole, pharmacist dispensing notice, and storage instructions. Manufactured by Alkem Laboratories Ltd. and distributed by Ascend Laboratories, LLC. The capsule is described as having a green opaque body and blue opaque cap.*

FDA Label Image

Topiramate-caps-200mg-30s (Topi 200 30s F13)

Label for Topiramate Extended-Release Capsules, USP 200 mg, an oral capsule with a pink opaque body and blue opaque cap. The label includes a dosage instruction of once daily and stipulates swallowing the capsule whole. It is Rx-only and contains 30 capsules. Manufactured by Alkem Laboratories Ltd., India, and distributed by Ascend Laboratories, LLC, Bedminster, NJ.*

FDA Label Image

Topiramate-caps-200mg-100s (Topi 200 100s F14)

Label for Topiramate Extended-Release Capsules USP, 200 mg strength, with 100 capsules per container. The label advises swallowing capsules whole without crushing or chewing and instructs pharmacists to dispense the medication guide. It lists the manufacturer as Alkem Laboratories Ltd., India, and the distributor as Ascend Laboratories, LLC, New Jersey. The label includes storage instructions and a barcode.*

FDA Label Image

Topiramate-caps-200mg-500s (Topi 200 500s F15)

Label for Topiramate Extended-Release Capsules, USP 200 mg by Ascend Laboratories, LLC. This label specifies a dosage of 200 mg once daily, with instructions to swallow the capsule whole and intact. The package size is 500 capsules. The capsule is described as pink opaque body with blue opaque cap. Manufacturer is Alkem Laboratories Ltd., India, and distributor is Ascend Laboratories, LLC, Bedminster, NJ. The label includes storage instructions and a barcode.*

FDA Label Image

Topiramate-caps-200mg-6s (Topi 200 6s F16)

Topiramate Extended-Release Capsules USP 200 mg carton label shows a 6-unit dose capsule package. Capsules have pink opaque bodies with blue opaque caps. Label includes dosing instruction to swallow whole, storage conditions, manufacturer Alkem Laboratories Ltd., and distributor Ascend Laboratories, LLC. NDC 67877-796-06.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.